ANI Pharmaceuticals, Inc.ANIPNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, above historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$63.12M
↑ 24% above average
Average (9y)
$50.90M
Historical baseline
Range
High:$106.60M
Low:$3.12M
CAGR
+5.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $63.12M | -40.8% |
| 2023 | $106.60M | +325.7% |
| 2022 | $25.04M | +703.6% |
| 2021 | $3.12M | -88.9% |
| 2020 | $28.13M | -53.7% |
| 2019 | $60.73M | -12.1% |
| 2018 | $69.10M | +20.9% |
| 2017 | $57.16M | +1.5% |
| 2016 | $56.31M | +42.0% |
| 2015 | $39.64M | - |